The document is an intimation of a series of one-on-one Analyst/Investor meetings.
The meetings are scheduled for Thursday, November 19, 2026, in Mumbai.
The stated purpose is compliance with Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The meetings are scheduled as follows:
Malabar Investments: In-person, 11.00 AM – 12.00 PM IST
Baroda Mutual Fund: In-person, 12.30 PM – 01.30 PM IST
Steinberg: In-person, 02.15 PM – 03.15 PM IST
Birla Mutual Fund: In-person, 04.00 PM – 05.00 PM IST
Carnelian: In-person, 05:30 PM – 06.30 PM IST
A note clarifies that the schedule is subject to changes due to exigencies on the part of the Analysts/Investors.
A presentation for the meeting is available at the provided URL: https://d28c6jni2fmamz.cloudfront.net/ECPH1Q2FY27_f8e43c260a.pdf
The disclosure will also be made available on the Company's website at www.starhealth.in.
The document contains standard compliance language but does not explicitly state whether unpublished price sensitive information (UPSI) will or will not be shared.
Additional Notes Section
The document is a formal letter of intimation addressed to the Listing Departments of BSE Limited and the National Stock Exchange of India Limited.
It is signed by Jayashree Sethuraman, Company Secretary & Compliance Officer.
The document reference number is SHAI/B & S/SE/157/2026-27.
No financial data, guidance, or strategic updates were disclosed in this announcement. The provided link points to a presentation deck, the contents of which are not summarized here.